✦ LIBER ✦

Reviewing therapies for primary biliary cirrhosis

Book ID: 120859561
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2003
Weight: 121 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200313950-00001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methotrexate therapy for primary biliary

Methotrexate therapy for primary biliary cirrhosis

✍ Nancy Bach; Carol Bodian; Henry Bodenheimer; Edward Croen; Paul D Berk; Swan N T 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 122 KB

Immunosupressive therapy for primary bil

Immunosupressive therapy for primary biliary cirrhosis

✍ Beukers, R.; Schalm, S.W. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 772 KB

Preventative therapy in primary biliary

Preventative therapy in primary biliary cirrhosis

✍ Floreani, Annarosa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Latest and Emerging Therapies for Primar

Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis

✍ Claudia O. Zein; Keith D. Lindor 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 360 KB

Review: Treatment of primary biliary cir

Review: Treatment of primary biliary cirrhosis

✍ JENNY HEATHCOTE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB

Ursodeoxycholic acid therapy in primary

Ursodeoxycholic acid therapy in primary biliary cirrhosis

✍ David E. J. Jones; Oliver F. W. James; Margaret F. Bassendine 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 703 KB

BackgroundlAims: A double-blind, placebo-controlled trial of ursodeoxycholic acid (UDCA) was conducted in 180 patients with primary biliary cirrhosis (PBC) to define the efficacy and safety of UDCA Efficacy was assessed by time to treatment failure defined as death; liver transplantation; histologic